Yeast mitochondrial DNA contains multiple promoters that are responsible for expression of its genes. The basic yeast mitochondrial promoter consists of a nonanucleotide consensus sequence [5'-ATATAA-GTA( +1)-3'] that must be recognized by transcription proteins, including mitochondrial RNA polymerase and any relevant frans-acting factors. Since mitochondrial RNA polymerase alone appeared unable to recognize a mitochondrial promoter, we examined the effects of providing accessory proteins to enable promoter function. After expression in Escherichia coli or purification from yeast mitochondria, two proteins were tested; they were ABF2 (a structural homologue of the human mitochondrial transcriptlonal activator mtTF1) and MTF1 (the gene product of a yeast locus known to exhibit a mitochondrial transcription phenotype). The results show that MTF1 specifies correct transcriptional initiation while ABF2 does not. We conclude that MTF1 is an essential key protein in yeast mitochondrial promoter function. Considering the increasing complexity of the mitochondrial transcription apparatus, we propose a nomenclature system for its components.
INTRODUCTION
The yeast Saccharomyces cerevisiae affords several well known advantages for the study of the synthesis and function of both mitochondrial DNA (mtDNA) and mitochondrial RNA (mtRNA). Paramount among these is the ability to use a combined biochemical and genetic approach in a system that is still viable under conditions of loss of mitochondrial function. With regard to transcription, it is known that yeast mtDNA has multiple promoters that are individually utilized for the production of tRNAs, rRNAs and mRNAs. It has also been suggested that a class of yeast mtDNA promoters is involved in priming mtDNA replication (1, 2) , perhaps in a manner analogous to the mode of leading-strand priming of mtDNA replication in vertebrates (3) .
The nature of yeast mtDNA promoters has been extensively examined at the level of m-acting DNA template sequence requirements. The available data point to the essential requirement of the nonanucleotide sequence 5'-ATATAAGTA(+1)-3' as the basal promoter element (1, (4) (5) (6) . No critical requirements for or effects due to flanking sequences at a distance have yet been observed. However, the identities of fra/u-acting proteins that can recognize and activate yeast mtDNA promoters have remained obscure. Yeast mtRNA polymerase (RPO41) has been sequenced (7) and is most similar to bacteriophages T3, T7 and SP6 among known RNA polymerases; it is likely comprised of a single catalytic polypeptide subunit (8, 9) .
There are additional proteins that have been suggested to play roles in yeast mitochondrial transcription. These include añ 43-kDa species (10) , an ~70-kDa species (11) and a small, basic HMG(high mobility group)-box-containing protein (termed HM [12, 13] , pl9/HM [14] or ABF2 [15] ). In particular, thẽ 43-kDa protein has been shown to confer promoter specificity to a yeast mtRNA polymerase fraction, and it has thus been termed specificity factor (9, 10) .
Interestingly, a yeast nuclear gene (termed MTF1 for mitochondria] transcriptional factor 1) has been sequenced that encodes a protein of similar size (39 kDa) to specificity factor, and which appears to be required for mitochondrial transcription (16) . Lisowsky and Michaelis (16) cloned the MTF1 by screening suppressors of RPO41 temperature sensitive-mutants. MTF1 contains a potential mitochondria! targeting presequence at its amino terminus and disruption of MTF1 results in loss of mtDNA (16) . These data suggest that MTF1 is a mitochondrial protein.
The simplest possibility for MTF1 function is that it acts in concert with yeast mtRNA polymerase. In addition, the yeast mitochondria] HMG-box protein ABF2 may be a homologue of a nucleus-encoded human mitochondrial protein (mtTFl) that recognizes and activates human mtDNA promoters (17, 18) .
Currently the two most obvious candidates for transcription factors participating with yeast mtRNA polymerase in transcriptional initiation are MTF1 and ABF2. In order to test directly for the effects of these proteins in transcription, we expressed the MTF1 gene in Escherichia coli to obtain significant amounts of the protein free of any other yeast protein and purified ABF2 to homogeneity from a yeast mitochondrial extract. The major conclusion derived from in vitro transcription assays is that MTF1 is a critical protein necessary and sufficient to confer promoter activation when provided with yeast mtRNA polymerase. ABF2, however, is unable to substitute for MTF1 in these reactions.
MATERIALS AND METHODS
Microbial strains and DNA manipulations Escherichia coli strains were DH5a and BL21(DE3) (19) . Yeast strains were BJ926 (deficient in some major proteases), YAM101A ab/2 (a, ade2-l, ura3-l, his3-ll,15, Standard methods were used for restriction fragment isolation, ligation, deletion mutagenesis using exonuclease m, and E. coli transformation (20) .
In vitro transcription assays Nonspecific RNA polymerase activity was assayed with the synthetic copolymer poly(dA-dT) as template. The reactions contained 10 mM Tris-HCl (pH 7.9), 10 mM MgCl 2 , 1 mM dithiothreitol (DTT), 100 /ig/ml RNase-free BSA, 400 ;tM ATP, 4 /iM UTP, 10 /ig/ml poly(dA-dT) (Sigma), and 0.1 /iM [a- 32 P]UTP at a specific activity of 800 Ci/mmol (NEN). Incubation was at 25°C for 30 min. Quantitation of synthesized RNA was carried out as described (21) .
Promoter-specific transcription was measured in a run-off assay using either C/al-digested plasmid pYml32 containing 14S rRNA gene (22) or /Ivall-digested H3on'5 containing a putative yeast mtDNA replication origin and its associated transcriptional promoter (gift of Dr. R.A.Butow, University of Texas Southwestern Medical Center) as template. A 25-/il transcription reaction contained 10 mM Tris-HCl (pH 7.9), 10 mM MgCl 2 , 1 mM DTT, 100/ig/ml RNase-free BSA, 10-40 mM KC1, 125 IJM each of ATP, CTP, and GTP, 0.5-1 fiM UTP, 10 jtg/ml template DNA, and 0.2-0.5 /tM [a- 32 P]UTP at a specific activity of 800 Ci/mmol (NEN). The standard transcription reaction was at 25°C for 30 min. The run-off transcription assay was performed as described (21) .
Overexpression of yeast mtRNA polymerase (RPO41)
A schematic diagram of the RPO41 overexpression plasmid is shown in Figure 1 threonine)]. This culture was diluted 50-fold into SCMGal-Ura (which used 2% galactose as a carbon source and is otherwise the same as SCM-Ura) to induce the expression of the RP041 gene. When the culture reached OD600=2-3, the cells were harvested and mitochondria were prepared.
Preparation of mitochondrial S-100 extract
Yeast cells were grown to late logarithmic phase at 30°C in the indicated media, harvested by centrifugation at 3,000Xg for 5 min at 4°C, washed once with deionized water, and subjected to spheroplast preparation according to Gasser (26) . Mitochondria were isolated from the spheroplasts as described (27) .
Mitochondria from about 100 g of yeast cells were resuspended in 30 ml of ice-cold lysis buffer containing 50 mM Tris-Cl (pH 7.9), 20 mM MgCl 2 , 0.2 mM EDTA, 2 mM DTT, 40% glycerol, and 2 X protease inhibitor mixture (1 mM PMSF, 2 /ig/ml each of pepstatin A, antipain, and leupeptin). Detergent lysis of mitochondria and salt extraction of protein were carried out as described for human mitochondria (28) . The lysate was centrifuged at 40,000 rpm for 60 min in a Type 75Ti rotor (100,000xg^), and the supernatant was designated mtS-100.
Purification of ABF2
Three hundred mg protein of mtS-100 prepared from BJ926 grown in 1 % yeast extract, 2% bactopeptone, 2% galactose, and 0.1% glucose was used to purify ABF2. Heparin Sepharose CL-6B, Blue Sepharose CL-6B, and Phenyl Sepharose CL^tB (Pharmacia) were performed according to Diffley and Stillman (29, 30) in buffer A containing 50 mM PIPES (pH 7.25), 20% glycerol, 0.2 mM EDTA, 1 mM DTT, and 1 Xprotease inhibitor mixture. In the Heparin-Sepharose chromatography, specific and nonspecific RNA polymerase activities overlapped with their activity peaks at -320 mM (NH^SO^ and -350 mM (NH 4 ) 2 SO 4 respectively, and ABF2 copurified with the nonspecific mtRNA polymerase activity. Fractions containing ABF2 and RNA polymerase activity were combined, adjusted to 300 mM (NH 4 ) 2 SO 4 with buffer A, and loaded onto a BlueSepharose CL-6B (Pharmacia) column. The flow-through fractions contained specificity factor activity. The column was washed sequentially with 300 mM (NH^SCy 1 M NaCl, or 2.5 M NaCl/5% Triton X-100 in buffer A. Fractions containing ABF2 and nonspecific RNA polymerase activity in the final wash were combined and designated Blue Sepharose mtRNA polymerase pool (BS mtRNA pol pool). After Triton X-100 was removed by a small Heparin-Sepharose column, ABF2 pool was subjected to a Phenyl Sepharose chromatography. ABF2-containing fractions were combined, dialyzed against 100 mM NaCl in buffer B [50 mM PIPES (pH 6.5), 10% glycerol, 0.2 mM EDTA, 2 mM DTT, and 1 Xprotease inhibitor mixture], and applied to a Mono S HR5/5 column (Pharmacia) equilibrated with 100 mM NaCl in buffer B. The column was washed with 10 ml of 100 mM NaCl in buffer B and eluted with a 20-ml linear gradient from 100 to 600 mM NaCl in buffer B. ABF2 eluted at ~33O mM NaCl. Fractions containing ABF2 were pooled, concentrated in a Centricon 10 concentrator (Amicon), and applied directly to a Superose 12 HR 10/30 column equilibrated with 500 mM NaCl in buffer B. Active fractions were concentrated in a Centricon 10, dialyzed against enzyme storage buffer [10 mM Tris-HCl (pH 7.9), 50% glycerol, 1 mM DTT, 0.1 mM EDTA, 100 mM KC1, and lx protease inhibitor mixture], and stored at -20°C.
Purification of yeast mtRNA polymerase
An mtS-100 (300 mg of protein) prepared from a 30-liter culture of the RPO41 overexpression strain was dialyzed against buffer C [25 mM HEPES-KOH (pH 7.4), 20% glycerol, 1 mM DTT, 0.1 mM EDTA, 1 Xprotease inhibitor mixture] and then applied to a DEAE-Sephacel (Pharmacia) column (2.5 cm X7.1 cm) equilibrated with buffer C. The column was washed with 70 ml of buffer C and then eluted with 95 ml of 150 mM KC1 in buffer C. The 150 mM KC1 eluent contained both nonspecific and specific RNA polymerase activities. Active fractions were pooled, adjusted to 300 mM KC1, and loaded onto a Blue-Sepharose CL-6B (Pharmacia) column (2.5 cm x4.0 cm). The column was washed sequentially with 50 ml each of buffer C containing 300 mM KC1, 800 mM NaCl, or 2.5 M NaCl/5% Triton X-100. Nonspecific RNA polymerase activity was found in last wash. Fractions containing nonspecific activity were combined, dialyzed against buffer C containing 150 mM KC1, and applied to a Heparin-Sepharose column (1.0cmx6.4cm). Following awash with 10 ml of buffer C containing 150 mM KC1, the column was eluted with a 50-ml linear gradient from 150 to 500 mM KC1 in buffer C. RPO41 eluted at -310 mM KC1. RPO41 and ABF2 copurified in above three column chromatographies. RPO41-active fractions were pooled, dialyzed against buffer C containing 150 mM KC1, and loaded onto a BioRex-70 (Bio-Rad) column (1.0 cmx5.8 cm) equilibrated with buffer C containing 150 mM KC1. After a wash with 9 ml of 150 mM KC1 in buffer C, the column was eluted with a 60-ml linear gradient from 150 to 500 mM KC1 in buffer C. RPO41 eluted at -320 mM KC1 and was separated from ABF2 whose peak elution was at 360 mM KC1. To concentrate RPO41, peak fractions of nonspecific activity were combined, dialyzed against 100 mM KC1 in buffer C, applied to a 1-ml BioRex-70 column, and eluted with 5 ml of 1 M KC1 in buffer C. Concentrated RPO41 fractions were subjected to gel filtration on a Superose 12 HR10/30 column (Pharmacia) by multiple runs in buffer C containing 100 rnM KC1. The elution volume of RPO41 is much larger than estimated from its molecular weight, which might be due to hydrophobic interaction between RPO41 and the column matrix. Fractions containing nonspecific activity of RNA polymerase were combined and ATP was added to a final concentration of 1 mM. This fraction was applied to a single-stranded DNA cellulose (Sigma) column (1 cmx4.4 cm) equilibrated and washed with buffer C containing 100 mM KC1 and 1 mM ATP, and eluted with a 60-ml linear gradient from 100 to 500 mM KC1 in buffer C plus 1 mM ATP. RPO41 was eluted at about 280 mM KC1. An aliquot of a peak fraction was dialyzed against storage buffer and stored at -20°C for all assays. The protein concentration of this dialyzed fraction was 0.34 mg/rnl. The cell pellet from a culture was resuspended in cracking buffer, heated, and electrophoresed on a 10% polyacrylamide gel. Lane 1, bacteria containing the pT7-7 alone; lane 2, bacteria containing the MTFI gene cloned in pT7-7. The apparent molecular weight in kDa is shown on the left (B) Specificity factor fraction of Blue-Sepharose chromatography can be substituted by rMTFl in an in vitro transcription assay. Protein in cracking buffer from 1 ml of induced culture was separated on a 10% SDS-polyacrylamide gel. The rMTFl band, and the region corresponding to the rMTFl band in the lane of bacteria containing pT7-7 alone [bacteria control (b-control)], were excised, eluted, and renatured. Three /il of rMTFl or b-control were assayed for transcription activity on 14S rRNA promoter alone, or with addition of 1 p\ of nonspecific RNA polymerase pool of BlueSepharose chromatography (BS mtRNA pol pool). Correctly initiated 373-nt transcripts are indicated by the arrow. (Q SDS-polyacrylamide gel analysis of purified RPO41. Ten fii of a peak fraction of ss-DNA cellulose chromatography was electrophoresed on a 7% polyacrylamide gel in the presence of SDS. This peak fraction was used for in vitro transcription assays. (D) One >il of renatured rMTFl, b-control or purified RPO41 alone (or their combinations as indicated) were assayed for specific transcription activity on the 14S rRNA promoter. M, 32 P-labeled Hpall fragments of pBR322. (E) The same as (D) except that Amlldigested plasmid H3ori5 containing the ori5 promoter was used as the template to assay for 228-nt correctly initiated transcripts. 7.9), 10% glycerol, 1 mM DTT, 0.1 mM EDTA, 1 Xprotease inhibitor mixture], loaded onto a 3-mJ DEAE-Sephacel column, and washed with Tris buffer until the A 2 go reading reached a constant value. The column was eluted with 15 ml of Tris buffer containing 150 mM KC1. No nonspecific RNA polymerase activity was found in the flow-through fraction when ABF2 wildtype extract was used, but about 70% of the nonspecific activity in the mtS-100 extract of the abj2~ deletion mutant was in the flow-through fraction. Nonspecific activity of mtRNA polymerase bound to the column was eluted with the 150 mM KC1 wash. Peak fractions of nonspecific activity, termed DEAE-mtRNA polymerase, were dialyzed against enzyme storage buffer and stored at -20°C.
DEAE-Sephacel chromatography of mtS-100 from

NaDodSO 4 (SDS)-polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis in the presence of SDS was performed according to Laemmli (31) . Protein was visualized by silver staining (32) .
MTFI expression in E.coli and protein isolation
The entire MTFI coding region (16) was amplified by PCR on 5. cerevisiae genomic DNA using a 5' primer with an EcoRI site followed by two extra nucleotides GC and a 3' primer with a HindUl site. The -1.05-kb PCR product was purified by electrophoresis onto DEAE-cellulose membrane (Schleicher and Schuell NA-45). The purified DNA fragment was digested with £coRI and HindJH and cloned into the same sites of the expression vector pT7-7 (33) . Lysogenic E. coli strain BL21(DE3), which contains a single copy of the gene for T7 RNA polymerase in the chromosome under control of the inducible lac\JW5 promoter (19) , was used to express MTFI. An overnight culture of transformed BL21(DE3) was diluted 1000-fold into a fresh LBampicillin medium and grown at 37°C until OD^ reached 0.6, when isopropyl-/3-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.4 mM to induce expression of MTFI. The cells were allowed to grow for 4 more hr, after which a 150-/il culture was pelleted, resuspended in 20-/tl cracking buffer (33) , heat denatured, and loaded onto a 10% SDS-polyacrylamide gel. The expressed MTFI was a fusion protein with 5 extra amino acids (met-ala-arg-ile-arg) at its amino-terminus, and was designated rMTFl (recombinant MTFI).
Renaturation of rMTFl from an SDS-polyacrylamide gel was performed according to Hager and Burgess (34) . Protein in cracking buffer from a 1-ml culture was electrophoresed in a 10% SDS-polyacrylamide gel. The rMTFl band and the region corresponding to the rMTFl band in the lane of pT7-7-alone transformant (bacteria control) were excised. Protein in the gel slices was eluted, precipitated, dissolved in 30 /J of 6 M guanidine-HC1 in dilution buffer [50 mM Tris-HCl (pH 7.9), 20% glycerol, 0.1 mg/ml BSA, 0.15 M NaCl, 1 mM DTT, and 0.1 mM EDTA], and incubated at room temperature for 15 min. The dissolved protein was diluted 50-fold in dilution buffer and allowed to renature for 4 hr at room temperature. The renatured protein was dialyzed against enzyme storage buffer and stored at -20°C. The dialyzed rMTFl had its concentration of 0.07 mg/ml.
RESULTS
Dissociation of mitochondria] transcription components in Blue-Sepharose chromatography
Fractions containing RNA polymerase activity from HeparinSepharose chromatography in the ABF2 purification procedure were capable of initiating transcription accurately on the mitochondrial 14S rRNA promoter to generate the expected 373-nucleotide(nt) transcript ( Figure 2B , lane 1). When the RNA polymerase activity pool of Heparin-Sepharose chromatography was subjected to chromatography on a Blue-Sepharose column, mtRNA polymerase was dissociated into two complementary fractions: core mtRNA polymerase containing nonspecific RNA polymerase activity and a specificity factor fraction. The core mtRNA polymerase fraction contained very little accurate transcription initiation activity and instead yielded a heterogeneous array of transcription products when assayed with the 14S rRNA promoter ( Figure 2B , lane 4). Core mtRNA polymerase was eluted in the 2.5 M NaCl/5% Triton X-100 wash (Figure 2A ).
Specificity factor activity was in the flow-through of the BlueSepharose column. When the flow-through fraction was added back to core mtRNA polymerase, accurate transcription initiation activity was restored ( Figure 2B , lane 5).
MTF1 is the specificity factor of mtRNA polymerase
We expressed MTF1 in E. coli to produce rMTFl and tested its function using an in vitro transcription assay. The expressed rMTFl was separated from bacterial protein on a SDSpolyacrylamide gel ( Figure 3A) , eluted from the gel, and allowed to renature. The rMTFl isolated by this method could substitute for the Blue-Sepharose flow-through fraction containing a specificity factor ( Figure 3B ). This result demonstrates that MTF1 has a direct role in transcription in vitro.
Since the Blue-Sepharose core mtRNA polymerase fraction contains a trace amount of specific transcription initiation activity, this result could be due to MTF1 acting as a general transcriptional activator. To resolve this, we overexpressed core mtRNA polymerase and purified RPO41 to near homogeneity ( Figure 3C ) and, more importantly, free of a specificity factor ( Figure 3D ). Purified RPOU and rMTFl are capable of initiating transcription accurately on the 14S rRNA promoter ( Figure 3D) ; this demonstrates that MTF1 is the specificity factor of yeast mtRNA polymerase. To ensure that the activity of these two components was not specific to the 14S rRNA promoter, we tested the yeast ori5 promoter; this promoter is located at a putative mtDNA replication origin (2) . The results in Figure 3E demonstrate that these components together activate this promoter in a fashion identical to the 14S rRNA promoter.
In order to demonstrate that the total amount of correctly initiated transcription was related to the amount of rMTFl present in the reaction, we tested the effect of increasing concentration of rMTFl in the presence of RPO41 ( Figure 4A ). The relative abundance of correctly initiated transcription was proportional to the amount of rMTFl present. As expected, the amount of accurate transcription initiation was also proportional to the amount of available RPO41 ( Figure 4B ).
ABF2 is not an alternative specificity factor
ABF2 is similar to human mtTFl in that both proteins are small, basic, abundant, HMG-box-containing DNA-binding proteins (15, 18) . Human mtTFl has the property of conferring promoter selectivity on an intrinsically nonselective or weakly selective RNA polymerase fraction (17, 21) . It was therefore interesting to test whether ABF2 could be an alternative specificity factor of yeast mtRNA polymerase. We partially purified mtRNA polymerase from the ABF2 wild-type strain and the abj2d eletion mutant by subjecting mitochondrial extracts to chromatography on a DEAE-Sephacel column. Both extracts had specific mtRNA polymerase activity on the 14S rRNA promoter ( Figure 5B ). This result indicates that ABF2 is not required for maintenance of the basal level of specific activity of the mitochondrial transcription apparatus, as judged by in vitro analysis.
However, this result did not exclude the possibility that ABF2 is an alternative specificity factor. We therefore purified ABF2 to homogeneity ( Figure 5A ), and assayed its intrinsic DNA binding activity as well as its transcription activity with purified RPO41 on the 14S rRNA promoter. Purified ABF2 bound the 14S rRNA promoter DNA (data not shown), indicating that it was in an active form, but RPO41 and ABF2 together did not show specific transcription initiation activity ( Figure 5C ). This result indicates that ABF2 does not enable yeast mtRNA polymerase to recognize a promoter in the absence of other transcription proteins. However, this result does not exclude a role for ABF2 in altering the efficiency of transcription initiation; we are currently testing this possibility.
DISCUSSION
These experiments suggest that two proteins are necessary and sufficient for accurate activation of yeast mitochondria! promoters. One of these, mtRNA polymerase, has not been purified to absolute homogeneity and the possibility remains that the enzyme we have used could contain a tightly associated additional component.
The second protein is MTF1, the sequence of which was determined by Lisowsky and Michaelis (16) who implicated MTF1 in mitochondrial transcription by genetic and biochemical tests. By in vitro transcriptional analyses we have shown that this protein confers promoter specificity in the yeast mitochondrial system. This central conclusion is consistent with the extensive biochemical work of Tabak and co-workers (9,10) who assigned the specificity factor as a protein of 43 kDa.
These results do not preclude the possibility that other proteins will be shown to be important for transcription of yeast mtDNA. In this regard, it will be of interest to learn the role(s) of ABF2 in yeast mitochondria given its apparent structural homology to the documented human mtDNA transcriptional activator mtTF 1 (15, 18) . ABF2 is unable, in the in vitro assay system, to substitute for MTF1 and does not enable yeast mtRNA polymerase to recognize a yeast mtDNA promoter. Therefore it may have no role in basal transcription or it may require a more sophisticated analysis (e.g., superhelical closed circular template) to reveal its function. After this manuscript had been completed, Jang and Jaehning (35) reported that the amino-terminal sequence of the 43-kDa protein identified by Schinkel et al. (9, 10 ) is identical to that of MTF1 gene product (16) . From gel retardation and footprinting assays on the yeast mitochondrial 21S rRNA promoter by Schinkel et al. (9) , it can be concluded that only MTF1 and RPO41 together can recognize the promoter.
Given the general and overlapping nature of the nomenclature that has been used to date, we propose a simplified system that should be able to be utilized for any mitochondrial species (Table  1 ). The proteins thus far known to be involved or directly implicated in mitochondria! transcription initiation are listed and additional proteins can be assigned in a straightforward manner. It will be of particular interest to learn if human mitochondria] transcription requires an h-mtTFB protein that would be similar to yeast MTF1 (sc-mtTFB) or whether a significant portion of the human specificity function relies on the interaction of hmtTFA (mtTFl) and core h-mtRNA polymerase.
